Pinned Tweet
Computable phenotype of Crohn’s disease health states➡️ transition probabilities b/w health states➡️ estimates real-world impact!
@JPAchkarMD @CCLRI @MedDecMak journals.sagepub.com/doi/ful…
Artificial intelligence is changing clinical and academic work. Join us live and learn how AI tools can support documentation, writing, workflow efficiency and more.
tinyurl.com/ycxtvbzf
@JKurowskiMD @ankurchugh02 @johnmrosen @KevinWatsonJrMD
Coming soon!!
5th Annual Kaplan Foundation Pediatric IBD Symposium on May 20th at Cleveland Clinic!
Speakers: Jeremy Adler MD, Stefan Holubar MD, and Nila Mistry Ambani MD.
Registration is free, in-person & virtual options with CME available.
clevelandclinicmeded.com/liv…
1
3
189
Jacob Kurowski retweeted
🏀 #OHSAA GIRLS BASKETBALL: Congratulations to Shaker Heights Laurel, the 2026 Division IV state champion!
Disgusted @CarelonRx - usual BS denial of Upa in pt 3rd Crohns med. P2P w/ pharmacist “who can’t approve off label usage” <18. Now I have to fax letter in. So you’ve wasted everyone’s time & kid’s still suffering. Need better legislation. @SCKimIBDMD @esyns @RepPhilRobinson
3
153
Replying to @MVPHealthCare
@MVPHealthCare denying a child’s right to infusion at our center for Crohns when they have significant medical trauma from IV placement. For 2 years, nursing & child life have worked so incredibly hard 2 help and they are doing so well. Why the denial now? Inflict more trauma?
2
6
171
Jacob Kurowski retweeted
#STARConsortium proudly announces program to validate a novel, next generation clinical trial endpoint in stricturing Crohn’s disease. #STAR partners with @mayoclinic @MotilentNews @alimentiv and industry to improve lives of patients with stricturing Crohn’s disease. Stay tuned..
Jacob Kurowski retweeted
So proud of NASPGHAN members of advocacy efforts, spending their Day on the Hill!
Advocacy is such an important part of our work in Pediatric GI!! #pedGIontheHill
👏 👏 👏
Not to be missed!
Meet #CCCongress26 Keynote, @IBD_FloMD! Join us Jan 22-24 in Vegas to connect with experts & the latest breakthroughs in #IBD care. Register by October 21 & SAVE bit.ly/4midzst @AmerGastroAssn
Sigh…not great
IBD is a tough disease. This Canadian study shows Ustekinumab endoscopic remission (Mayo 0) rates at 12 months barely above 12% in bio-exposed population. Very few patients are disease free. #GITwitter #MedEd
journals.lww.com/ajg/fulltex…
Proud to share @ElizabethHilow work in fellowship demonstrating ⬇️ resilience in IBD pts when changing therapies in @Children_MDPI with @JBarryMDPedsGI @NMistryAmbani mdpi.com/2227-9067/12/8/1062
1
1
107
Jacob Kurowski retweeted
Our recent study on ASUC.
Colectomy at
Discharge-8%
1 yr-13.5%
3yr -16.1%
5yr- 17.4%
Steroid responders and non-responders have similar outcomes.
Day-3 Oxford criteria remain relevant in post biologic era
@vipuljairath @virgisolitano
academic.oup.com/ecco-jcc/ad…
Jacob Kurowski retweeted
Multidisciplinary SAR Consensus Recommendations for Defining Small Bowel Crohn Disease Strictures at CT and MR Enterography | Radiology pubs.rsna.org/doi/10.1148/ra… @BariDaneMD @SAR_IBD_DFP @radiology_rsna – at Clayton, MO
Last week - 4th Peds IBD Symposium thanks2 Kaplan Foundation. Amazing talks by @TStappenbeckMD on new frontiers in wound repair, @SCKimIBDMD, Emily Geist PhD, Diana Schnee RD on RW diet implementation, & Alan Moss CSO @CrohnsColitisFn on prevent IBD trials w/ diet & meds!
3
9
355
Jacob Kurowski retweeted
Very excited to share a comprehensive (150+ page) new resource for caregivers/ families of children living with IBD and/or autoimmune liver disease.
This Caregiver Coping resource addresses a broad array of common concerns and questions, from navigating diagnosis, to managing family dynamics, building resilience, coping with stressful situations, and practical strategies for school, travel, and finances / insurance. We address special challenges for VEO families, AILD, multiple diagnoses, and surgery.
We link to other resources on specific topics where high quality resources exist. As a living document, this can and should also evolve and improve.
My goal was to make this a highly practical resource, to ensure parents’ feelings, learnings, experiences, and expertise are front and center, and, as importantly, to drive what I call “realistic hope”. Too many IBD sites and pamphlets are utterly terrifying to many patients and families.
This resource was co-developed by @ImproveCareNow ‘s Parent & Family Advisory Council (PFAC), which I co-Chair, the Autoimmune Liver Disease Network for Kids (A-LiNK), and the Social Workers & Psychologists group (SWAP). All 12 people involved were absolutely amazing, contributing significantly to this true group effort. Special thanks to my co-Chair, Heidi Riechel for being a relentless advocate for mental health, to Jennie David for her leadership, and to Sarah Nocito for the outstanding editing and formatting.
Explore it, share it: bit.ly/CCR_2025
Jacob Kurowski retweeted
Excited to see this important work out in @IBDJournals from our @SMCH_IBD_Celiac team that uncovers new potential avenues to advance wellness in youth with IBD through self compassion!
Be kind🫶 to yourself! @NicoleNieman, Rachel Bensen, Ann Ming Yeh, and Anava Wren show in @IBDJournals a strong association of self-compassion and multiple measures of mental health and global wellness in adolescents and YAs with #IBD. academic.oup.com/ibdjournal/…
A huge volume of work & success led by @IBD_FloMD !
Replying to @DDWMeeting
@DDWMeeting #DDW2025 #STARConsortium Industry Board Meeting. Tremendous progress by the team with the first trial #Agomab @STENOVA on the way with encouraging interim results. Onwards and upwards through industry with academia collaboration... @tinahamd @MRegueiroMD @vipuljairath
Jacob Kurowski retweeted
Replying to @IBD_FloMD
@IBD_FloMD promising phase 2a STENOVA interim results TGFb receptor antagonist, AGMB129, in symptomatic >/= 1 TI stricture.
👉TGF-b major pro-fibrotic growth factor.
➡️ mean 17.5 yrs CD, fcal 373, SESCD7
➡️sig ⬇️ fibrotic &inflamm pathway
➡️improved stricture passability






























